300254 On Other Exchanges
Symbol
Exchange
300254 is not on other exchanges.

shanxi c&y pharmaceutical-a (300254) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANXI C&Y PHARMACEUTICAL-A (300254)

Related News

No related news articles were found.

shanxi c&y pharmaceutical-a (300254) Related Businessweek News

No Related Businessweek News Found

shanxi c&y pharmaceutical-a (300254) Details

ShanXi C&Y Pharmaceutical Group Co., LTD. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers anti-infective injection products of mezlocillin sodium sulbactam sodium and fosfomycin tromethamine powder; and pregnant and infant care, urology health, anti-infective, Chinese medicine, and other products, as well as teabags. The company was formerly known as Shanxi C&Y Pharmaceutical Co., LTD. and changed its name to Shanxi C&Y Pharmaceutical Group Co., LTD. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is based in Datong, China.

Founded in 2005

shanxi c&y pharmaceutical-a (300254) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanxi c&y pharmaceutical-a
ShanXi C&Y Pharmaceutical Group Co., LTD., 2016 Earnings Call, Apr 18, 2017

ShanXi C&Y Pharmaceutical Group Co., LTD., 2016 Earnings Call, Apr 18, 2017

Shanxi C&Y Pharmaceutical Group Co.,Ltd Proposes Final Cash Dividend for the Year 2016

Shanxi C&Y Pharmaceutical Group Co.,Ltd proposed a final cash dividend (tax included) of CNY 0.50000000 per ten shares for the year 2016.

Shanxi C&Y Pharmaceutical Group Co.,Ltd. to Report Fiscal Year 2016 Results on Apr 06, 2017

Shanxi C&Y Pharmaceutical Group Co.,Ltd. announced that they will report fiscal year 2016 results on Apr 06, 2017

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

300254 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300254.
View Industry Companies
 

Industry Analysis

300254

Industry Average

Valuation 300254 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANXI C&Y PHARMACEUTICAL-A, please visit www.cy-pharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.